Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant.
Bandettini
R
R
Castagnola
E
E
Calvillo
M
M
Micalizzi
C
C
Ravegnani
M
M
Pescetto
L
L
Manzitti
C
C
Soro
O
O
Ricagni
L
L
Lanino
E
E
Miano
M
M
Cuzzubbo
D
D
Conte
M
M
Morreale
G
G
Faraci
M
M
D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008297:Male; D016919:Meningitis, Cryptococcal / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D011743:Pyrimidines / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole